Cargando…
Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits
Autores principales: | Drucker, Daniel J., Sherman, Steven I., Gorelick, Fred S., Bergenstal, Richard M., Sherwin, Robert S., Buse, John B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809297/ https://www.ncbi.nlm.nih.gov/pubmed/20103558 http://dx.doi.org/10.2337/dc09-1499 |
Ejemplares similares
-
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
por: Skyler, Jay S., et al.
Publicado: (2009) -
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
por: Nathan, David M., et al.
Publicado: (2009) -
Diabetes and Cancer: A consensus report
por: Giovannucci, Edward, et al.
Publicado: (2010) -
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Inzucchi, Silvio E., et al.
Publicado: (2012) -
Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
por: Rajpathak, Swapnil N., et al.
Publicado: (2009)